Drug recall
ADACEL TDAP VACCINE, SYR ADLT2MG-2.5MG-5MG/0.5ML (5/BX), Catalog No. 49281040020
FDA recall event 82376 · Class III · MCKESSON MEDICAL
Key facts
| Event ID | 82376 |
|---|---|
| Recall numbers | B-0514-2019, B-0515-2019, B-0516-2019, B-0517-2019, B-0518-2019, B-0519-2019, B-0520-2019, B-0521-2019 |
| Recalling firm | MCKESSON MEDICAL |
| Product type | Biologics |
| Products | ADACEL TDAP VACCINE, SYR ADLT2MG-2.5MG-5MG/0.5ML (5/BX), Catalog No. 49281040020, AFLURIA 2018, QUAD SYR 0.5ML (10DOSE/BX), Catalog No. 33332031801, Bexsero, PFS 0.5 ml (1/BX), Catalog No. 58160097606, BOOSTRIX, TDAP SYR 2.5-8.5MG/0.5ML 0.5ML (10/PK) SMKLP, Catalog No. 58160084252, MENVEO VACCINE, SDV 10-5MG/0.5, Catalog No. 58160095509 and 3 more |
| Classification | Class III |
| Status | Terminated |
| Voluntary or mandated | Firm Initiated |
| Reason for recall | Multiple vaccines, lacking assurance of proper storage temperatures, were distributed. |
| Initiation date | Feb 15, 2019 |
| Report date | May 22, 2019 |
| Termination date | Jul 26, 2022 |
| City | Richmond |
| State | VA |
| Country | United States |
| FEI number | 3012855303 |
At a glance
- 1–9 Products in this recall
- None FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: